lvrachЛечащий ВрачLechaschi Vrach1560-51752687-1181lvrach-494Research ArticleСтатьиЦитомегаловирусная инфекция в практике врача: современный алгоритм диагностики и леченияCytomegaloviral infection in therapeutic practice: modern algorithm of diagnostics and treatmentИзвековаИ. Я.IzvekovaI. Ya.izvekova@inbox.ruМихайленкоМ. А.MikhaylenkoM. A.noemail@neicon.ruКрасноваЕ. И.KrasnovaE. I.noemail@neicon.ruФГБОУ ВО НГМУ МЗ РФRussian Federation201823062021049090Copyright © Извекова И.Я., Михайленко М.А., Краснова Е.И., 20212021Извекова И.Я., Михайленко М.А., Краснова Е.И.Izvekova I.Y., Mikhaylenko M.A., Krasnova E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/494

В статье проанализированы опубликованные данные по вопросам адекватной диагностики антенатальной и постнатальной цитомегаловирусной инфекции (ЦМВИ), а также лечению острых ЦМВИ у беременной, плода и новорожденного. Представлены отечественные клинические рекомендации по диагностике и лечению врожденной ЦМВИ, разработанные Российской ассоциацией специалистов перинатальной медицины в 2016 г.; первые неофициальные международные рекомендации по вопросам диагностики и лечения врожденной ЦМВИ.

The article gives analysis of the data on the issues of relevance of diagnostics of antenatal and postnatal cytomegaloviral infection (CMVI), as well as treatment of acute CMVI in the pregnant, fetus and newborns. National clinical guidelines on diagnostics and treatment of congenital CMVI developed by the Russian Association of antenatal medicine in 2016, were presented; as well as the first unofficial international guidelines on the issues of diagnostics and treatment of congenital CMVI. 

Актуальная темаЦитомегаловирусная инфекцияДетиДиагностикаЛечениеcytomegaloviral infectionchildrendiagnosticstreatmentReferencesGrose С., Johanson D. C. Transmission of Cytomegalovirus, Epstein–Barr Virus, and Herpes Simplex Virus Infections: From the Lucy Australopithecus Epoch to Modern-Day Netherlands // The Journal Of Pediatrics. 2016, vol. 170. www.jpeds.com.Grose С., Johanson D. C. Transmission of Cytomegalovirus, Epstein–Barr Virus, and Herpes Simplex Virus Infections: From the Lucy Australopithecus Epoch to Modern-Day Netherlands // The Journal Of Pediatrics. 2016, vol. 170. www.jpeds.com.Rook G. A. W., Raison C. L., Lowry C. A. Microbial ‘old friends’, immunoregulation and socioeconomic status // Clinical and Experimental Immunology. 2014; 177: 1–12.Rook G. A. W., Raison C. L., Lowry C. A. Microbial ‘old friends’, immunoregulation and socioeconomic status // Clinical and Experimental Immunology. 2014; 177: 1–12.Gandhi M. K., Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments // Lancet Infect Dis. 2004; 4: 725–738.Gandhi M. K., Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments // Lancet Infect Dis. 2004; 4: 725–738.Gossman W. G., Bhimji S. S. Cytomegalovirus. [Updated 2017 Oct 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017.Gossman W. G., Bhimji S. S. Cytomegalovirus. [Updated 2017 Oct 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017.Jun van den Pol A. N. Cytomegalovirus Cell Tropism, Replication, and Gene Transfer in Brain // The Journal of Neuroscience. 1999, 19 (24): 10948–10965.Jun van den Pol A. N. Cytomegalovirus Cell Tropism, Replication, and Gene Transfer in Brain // The Journal of Neuroscience. 1999, 19 (24): 10948–10965.Kallemeijn1 M. J., Boots А. M. H., van der Klift1 M. Y. et al. Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gamma-delta T-cells. www.nature.com/scientificreports2017.Kallemeijn1 M. J., Boots А. M. H., van der Klift1 M. Y. et al. Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gamma-delta T-cells. www.nature.com/scientificreports2017.Юлиш Е. И. Цитомегаловирусная инфекция у детей: подходы к лечению при различном течении инфекционного процесса // Здоровье ребенка. 2015, 4 (64).Юлиш Е. И. Цитомегаловирусная инфекция у детей: подходы к лечению при различном течении инфекционного процесса // Здоровье ребенка. 2015, 4 (64).Jones R. P., Goldeck D. Unexpected and unexplained increase in death due to neurological disorders in 2012 in England and Wales: Is cytomegalovirus implicated? // Medical Hypotheses. 2014, 83, 25–31.Jones R. P., Goldeck D. Unexpected and unexplained increase in death due to neurological disorders in 2012 in England and Wales: Is cytomegalovirus implicated? // Medical Hypotheses. 2014, 83, 25–31.Schleiss M. R. Congenital Cytomegalovirus Infection: Improved Understanding of Maternal Immune Responses That Reduce the Risk of Transplacental Transmission // Clinical Infectious Diseases. 2017, vol. 65, Issue 10, p. 1666–1669. https://doi.org/10.1093/cid/cix626.Schleiss M. R. Congenital Cytomegalovirus Infection: Improved Understanding of Maternal Immune Responses That Reduce the Risk of Transplacental Transmission // Clinical Infectious Diseases. 2017, vol. 65, Issue 10, p. 1666–1669. https://doi.org/10.1093/cid/cix626.Emery V. C., Lazzarotto T. Cytomegalovirus in pregnancy and the neonate [version 1; referees: 2 approved] // F1000 Research. 2017, 6 (F1000 Faculty Rev): 138. DOI: 10.12688/f1000 research.10276.1.Emery V. C., Lazzarotto T. Cytomegalovirus in pregnancy and the neonate [version 1; referees: 2 approved] // F1000 Research. 2017, 6 (F1000 Faculty Rev): 138. DOI: 10.12688/f1000 research.10276.1.Dreher A. M., Arora N., Fowler K. B. et al. Spectrum of Disease and Outcome in Children with Symptomatic Congenital Cytomegalovirus Infection // J Pediatr. 2014. http://dx.doi.org/10.1016/j.jpeds.2013.12.007.Dreher A. M., Arora N., Fowler K. B. et al. Spectrum of Disease and Outcome in Children with Symptomatic Congenital Cytomegalovirus Infection // J Pediatr. 2014. http://dx.doi.org/10.1016/j.jpeds.2013.12.007.Malinger G., Lev D., Lerman-Sagie T. Imaging of fetal cytomegalovirus infection // Fetal Diagn Ther. 2011; 29 (2): 117–126.Malinger G., Lev D., Lerman-Sagie T. Imaging of fetal cytomegalovirus infection // Fetal Diagn Ther. 2011; 29 (2): 117–126.Lazzarotto T., Guerra B., Gabrielli L., Lanari M., Landini M. P. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy // Clin Microbiol Infect: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011; 17 (9): 1285–1293.Lazzarotto T., Guerra B., Gabrielli L., Lanari M., Landini M. P. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy // Clin Microbiol Infect: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011; 17 (9): 1285–1293.McGregor Alastair. Diagnostics in fever of unknown origin — an introduction. Новости с конгресса ECCMID 2017. Сессия «Встреча с экспертом», 23 апреля 2017.McGregor Alastair. Diagnostics in fever of unknown origin — an introduction. Новости с конгресса ECCMID 2017. Сессия «Встреча с экспертом», 23 апреля 2017.Toriyabe K., Morikawa F., Minematsu T. Anti-cytomegalovirus immunoglobulin M titer for congenital infection in first-trimester pregnancy with primary infection: a multicenter prospective cohort study // Journal of Perinatology, 2017, 12 October. DOI: 10.1038/jp.2017.133.Toriyabe K., Morikawa F., Minematsu T. Anti-cytomegalovirus immunoglobulin M titer for congenital infection in first-trimester pregnancy with primary infection: a multicenter prospective cohort study // Journal of Perinatology, 2017, 12 October. DOI: 10.1038/jp.2017.133.Tanimura К., Tairaku S. et al. Prediction of congenital cytomegalovirus infection in high-risk pregnant women // Clin Infect Dis. 2017; 64 (2): 159–165. DOI: https://doi.org/10.1093/cid/ciw707.Tanimura К., Tairaku S. et al. Prediction of congenital cytomegalovirus infection in high-risk pregnant women // Clin Infect Dis. 2017; 64 (2): 159–165. DOI: https://doi.org/10.1093/cid/ciw707.Tanimura K., Tairaku S., Morioka I. et al. Universal screening with use of IgG avidity for congenital cytomegalovirus infection // Clin Infect Dis. 2017; 65 (10). https://doi.org/10.1093/cid/cix626.Tanimura K., Tairaku S., Morioka I. et al. Universal screening with use of IgG avidity for congenital cytomegalovirus infection // Clin Infect Dis. 2017; 65 (10). https://doi.org/10.1093/cid/cix626.Sonoyama A., Ebina Y., Morioka I. et al. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection // J Med Virol. 2012; 84 (12): 1928–1933.Sonoyama A., Ebina Y., Morioka I. et al. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection // J Med Virol. 2012; 84 (12): 1928–1933.Rawlinson W. D., Boppana S. B., Fowler K. B., Kimberlin D. W. et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy // Lancet Infect Dis. 2017. http://dx.doi.org/10.1016/S1473–3099 (17)30143–3.Rawlinson W. D., Boppana S. B., Fowler K. B., Kimberlin D. W. et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy // Lancet Infect Dis. 2017. http://dx.doi.org/10.1016/S1473–3099 (17)30143–3.Nishida K., Morioka I., Nakamachi Y. et al. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment // Brain Dev. 2016; 38 (2): 209–216.Nishida K., Morioka I., Nakamachi Y. et al. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment // Brain Dev. 2016; 38 (2): 209–216.Nigro G., Capretti I., Manganello A. M., Best A. M., Adler S. P. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight // J Matern Fetal Neonatal Med. 2015; 28: 1–4.Nigro G., Capretti I., Manganello A. M., Best A. M., Adler S. P. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight // J Matern Fetal Neonatal Med. 2015; 28: 1–4.Revello M. G. et al. A randomized, phase 2 trial of prevention of congenital cytomegalovirus // N Engl J Med. 2014, Apr 2; 370: 1316. http://dx.doi.org/10.1056/NEJMoa1310214.Revello M. G. et al. A randomized, phase 2 trial of prevention of congenital cytomegalovirus // N Engl J Med. 2014, Apr 2; 370: 1316. http://dx.doi.org/10.1056/NEJMoa1310214.Bl?zquez-Gamero D. et al. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid // The Journal of Maternal-Fetal & Neonatal Medicine. 2017, Oct, р. 1–9. http://dx.doi.org/10.1080/14767058.2017.1387890.Bl?zquez-Gamero D. et al. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid // The Journal of Maternal-Fetal & Neonatal Medicine. 2017, Oct, р. 1–9. http://dx.doi.org/10.1080/14767058.2017.1387890.Puliyanda D. P., Silverman N. S., Lehman D. et al. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient // Transpl Infect Dis. 2005; 7: 71–74.Puliyanda D. P., Silverman N. S., Lehman D. et al. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient // Transpl Infect Dis. 2005; 7: 71–74.Brandy R. C., Schleiss M. R., Witte D. P., Siddiqi T. A., Fame P. T. Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease // Pediatr Infect Dis. J. 2002; 21: 796–797.Brandy R. C., Schleiss M. R., Witte D. P., Siddiqi T. A., Fame P. T. Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease // Pediatr Infect Dis. J. 2002; 21: 796–797.Jacquemard F., Yamamoto M., Costa J. M. et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection // BJOG. 2007; 114: 1113–1121.Jacquemard F., Yamamoto M., Costa J. M. et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection // BJOG. 2007; 114: 1113–1121.Leruez-Ville M., Ghout I., Bussieres L. et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study // Am J Obstet Gynecol. 2016; 215: 462 e1–462.Leruez-Ville M., Ghout I., Bussieres L. et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study // Am J Obstet Gynecol. 2016; 215: 462 e1–462.Kimberlin D. W, Jester P. M, Sanchez P. J. et al. Valganciclovir for symptomatic congenital cytomegalovirus disease // N Engl J Med. 2015; 372: 933–943.Kimberlin D. W, Jester P. M, Sanchez P. J. et al. Valganciclovir for symptomatic congenital cytomegalovirus disease // N Engl J Med. 2015; 372: 933–943.Marsico С., Kimberlin D. W. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment // Italian Journal of Pediatrics. 2017, 43: 38.Marsico С., Kimberlin D. W. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment // Italian Journal of Pediatrics. 2017, 43: 38.Hamprecht К., Goelz R. Postnatal Cytomegalovirus Infection Through Human Milk in Preterm Infants // Clinics in Perinatology. 2016, vol. 44, is. 1, p. 121–130.Hamprecht К., Goelz R. Postnatal Cytomegalovirus Infection Through Human Milk in Preterm Infants // Clinics in Perinatology. 2016, vol. 44, is. 1, p. 121–130.Schleiss M. R., Permar S. R., Plotkin S. A. Progress Toward Development of a Vaccine Against Congenital Cytomegalovirus Infection // Clin. Vaccine Immunol. 2017. DOI: 10.1128/CVI.00268–17.Schleiss M. R., Permar S. R., Plotkin S. A. Progress Toward Development of a Vaccine Against Congenital Cytomegalovirus Infection // Clin. Vaccine Immunol. 2017. DOI: 10.1128/CVI.00268–17.

The authors declare that there are no conflicts of interest present.